Small-molecule drugs are targeted cancer medicines<\/a> that doctors use to treat mesothelioma from the inside of the cell. Mesothelioma tumors rely on certain proteins and pathways to survive. Small molecule inhibitors work by entering the cancer cells and blocking those pathways, which weakens the tumor and makes it easier to treat.<\/p>\n Because these drugs are very small, they can move through the outer layer of mesothelioma<\/a> cells and reach key proteins inside the cell.<\/p>\n Many mesothelioma tumors rely on internal “fuel lines” or communication systems to grow. These critical systems are often linked to NF2 gene changes and a network called the YAP\u2013TEAD signaling pathway. NF2 is a gene that helps keep cell growth under control, and YAP-TEAD are proteins that switch growth signals on when they join together.<\/p>\n When small-molecule drugs block these pathways, they can:<\/strong><\/p>\n Some small-molecule medicines also act as angiogenesis inhibitors<\/a>. They work outside the cell by preventing tumors from forming the blood vessels they need to grow.<\/p>\n Find a top mesothelioma doctor who can review whether small molecule therapy fits your treatment plan. Our Free Doctor Match <\/strong>service can connect you with specialists in your area and across the country.<\/p>\n\n